Senda hires O’Neill as CSO

mRNA medicine company Senda Biosciences Inc. hired Luke O’Neill as CSO. O’Neill is a member of Senda’s board and scientific advisory board, and a professor of biochemistry at Trinity College Dublin.

Ziphius Vaccines N.V., which is developing self-amplifying RNA-based vaccines and therapeutics, appointed Johan Van Hoof as chief scientific adviser. Van Hoof was global therapeutic area head for infectious diseases and vaccines at Janssen Pharmaceuticals unit of Johnson & Johnson (NYSE:JNJ)...